Skip to content

Case

New technology to reduce blood loss after injury

When a critical injury to an arm or leg results in intense blood loss, an emergency tourniquet must be applied. Through innovative solutions, competence in industrialisation and eco-design, Semcon in Norway is supporting health tech company Aristeia in the development of its unique tourniquet for bleeding control.

CustomerAristeia

IndustryLife Science

CompetencesDesign & User ExperienceProduct Development

Background

Aristeia’s patented solution is easy and quick to use, providing a market leading pressure distribution thanks to the geared pull cord mechanism, the robust strap guide, and the on-device user instructions. The optimised pressure distribution reduces pain and discomfort.

Solution

Semcon is collaborating with Aristeia to advance the performance and design of the startup’s current Gen4 prototype as well as exploring the best manufacturing procedures for serial production. The prototype will be ready for testing in November 2021. Aristeia is a startup that is partly funded by Innovation Norway and The Research Council of Norway.

Read more about Aristeia

With more than 35 years of experience in the life science industry, Semcon helps customers throughout the entire product and production development process, including product information, plus expert skills meeting niche needs.

Read more about Semcon’s offering in life science.

Contact us

Frode Christiansen, Semcon

Frode Christiansen

Manager Sales and Business Development